ENTRY       D09961                      Drug
NAME        Samalizumab (USAN/INN)
FORMULA     C6542H10086N1702O2102S46
EXACT_MASS  147594.181
MOL_WEIGHT  147685.2144
SEQUENCE    (Heavy chain)
            QVQLQQSGSE LKKPGASVKI SCKASGYSFT DYIILWVRQN PGKGLEWIGH IDPYYGSSNY
            NLKFKGRVTI TADQSTTTAY MELSSLRSED TAVYYCGRSK RDYFDYWGQG TTLTVSSAST
            KGPSVFPLAP CSRSTSESTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SNFGTQTYTC NVDHKPSNTK VDKTVERKCC VECPPCPAPP VAGPSVFLFP
            PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE QFNSTYRVVS
            VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS QEEMTKNQVS
            LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSRLTVDK SRWQEGNVFS
            CSVMHEALHN HYTQKSLSLS LG
            (Light chain)
            DIQMTQSPSS LSASIGDRVT ITCKASQDIN SYLSWFQQKP GKAPKLLIYR ANRLVDGVPS
            RFSGSGSGTD YTLTISSLQP EDFAVYYCLQ YDEFPYTFGG GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H144-H200, H257-H317, H363-H421, H219-H'219, H220-H'220, H223-H'223, H226-H'226, L23-L88, L134-L194, H131-L214)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-CD200 antibody
  TYPE      Monoclonal antibody
TARGET      CD200 [HSA:4345] [KO:K06556]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD200
                 D09961  Samalizumab (USAN/INN)
DBLINKS     PubChem: 124490632
///
